https://www.investors.com/news/technology/verv-stock-skyrockets-after-lilly-inks-deal-for-its-gene-editing-drugs/
0
0
10/31/23 at 9:04pm
Organization
Investor's Business Daily
Author
Investor's Business Daily
Eli Lilly now owns the opt-in rights to three more of Verve's cardiovascular drugs.
Create an account
or login to join the discussion